{"success":true,"data":{"pressRelease":{"id":"94197","rtpr_id":"nGNX2Yzm8B","ticker":"ADMA","exchange":"NASDAQ","all_tickers":["ADMA"],"title":"Portnoy Law Firm Announces Class Action on Behalf of ADMA Biologics, Inc. Investors","author":"Globe Newswire","published_at":"2026-07-21T14:45:30.091Z","article_body":"LOS ANGELES, July 21, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm\n(https://www.globenewswire.com/Tracker?data=ZC_eVrICyOavjygLgyZLs0Iwtju-WH9V_CVQ2_m-PuSxbgUIqDcf7WrVkAGSrI_SmXBbqKi4Kl4Uc8sZWZshT-6elQOMRSwnbDhGDI9TaTCSpjNxAh_7jD2UJ0SyY7yJ)\nadvises ADMA Biologics, Inc., (“ADMA” or the \"Company\") (NASDAQ: ADMA)\ninvestors of a class action on behalf of investors that bought securities\nbetween August 9, 2024 and March 25, 2026, inclusive (the “Class Period”).\nADMA investors have until August 10, 2026 to file a lead plaintiff motion.\n\nInvestors are encouraged to contact attorney Lesley F. Portnoy\n(https://www.globenewswire.com/Tracker?data=VDAiIT4yeeOHBXAaDvTqLMN7BdBZilDAGgamaj3eVK0XJI1qyjYm3CSFEmmxJCW9QhakHJOQDpThIdnMfVCKyb7IVLajfAcBwYOAPfGs4WP1UUgELPT3r875K1TkN4QI), by\nphone 310-692-8883 or email\n(https://www.globenewswire.com/Tracker?data=k26wgAcephs2lY1Ufw5PodOYK9UDaJlBeid2oaj4meiu3seRoiV7SOUBqkvfvl-JpCwbCo2j1ERJvx6pWmLKHSLJz_o1DqK_7dLWxtwPj10=):\nlesley@portnoylaw.com, to discuss their legal rights, or join the case via\nhttps://portnoylaw.com/adma-biologics-inc. The Portnoy Law Firm can provide a\ncomplimentary case evaluation and discuss investors’ options for pursuing\nclaims to recover their losses.\n\nAccording to the Complaint, ADMA Biologics and certain of its executives are\ncharged with failing to disclose material information in the Offering\nDocuments, violating federal securities laws.\n\nThe alleged false and misleading statements and omissions include, but are not\nlimited to, that: (i) the Company engaged in an undisclosed related party\ntransaction; (ii) the Company used channel stuffing to create an appearance of\nrevenue; (iii) the Company lacked adequate internal controls; (iv) as a\nresult, Defendants’ statements about the Company’s business, operations,\nand prospects were materially false and misleading and/or lacked a reasonable\nbasis at all relevant times. When the true details entered the market, the\nlawsuit claims that investors suffered damages.\n\nThe Portnoy Law Firm represents investors in pursuing claims caused by\ncorporate wrongdoing. The Firm’s founding partner has recovered over $5.5\nbillion for aggrieved investors. Attorney advertising. Prior results do not\nguarantee similar outcomes.\n\nLesley F. Portnoy, Esq.\nAdmitted CA, NY and TX Bar\nlesley@portnoylaw.com\n310-692-8883\nwww.portnoylaw.com\n\nAttorney Advertising\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/ea0dd9c0-6e41-4d5a-ad27-b277677af6df)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX2Yzm8B","title":"Portnoy Law Firm Announces Class Action on Behalf of ADMA Biologics, Inc. Investors","author":"Globe Newswire","ticker":"ADMA","created":"2026-07-21T14:45:30.091Z","tickers":["ADMA"],"exchange":"NASDAQ","article_body":"LOS ANGELES, July 21, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm\n(https://www.globenewswire.com/Tracker?data=ZC_eVrICyOavjygLgyZLs0Iwtju-WH9V_CVQ2_m-PuSxbgUIqDcf7WrVkAGSrI_SmXBbqKi4Kl4Uc8sZWZshT-6elQOMRSwnbDhGDI9TaTCSpjNxAh_7jD2UJ0SyY7yJ)\nadvises ADMA Biologics, Inc., (“ADMA” or the \"Company\") (NASDAQ: ADMA)\ninvestors of a class action on behalf of investors that bought securities\nbetween August 9, 2024 and March 25, 2026, inclusive (the “Class Period”).\nADMA investors have until August 10, 2026 to file a lead plaintiff motion.\n\nInvestors are encouraged to contact attorney Lesley F. Portnoy\n(https://www.globenewswire.com/Tracker?data=VDAiIT4yeeOHBXAaDvTqLMN7BdBZilDAGgamaj3eVK0XJI1qyjYm3CSFEmmxJCW9QhakHJOQDpThIdnMfVCKyb7IVLajfAcBwYOAPfGs4WP1UUgELPT3r875K1TkN4QI), by\nphone 310-692-8883 or email\n(https://www.globenewswire.com/Tracker?data=k26wgAcephs2lY1Ufw5PodOYK9UDaJlBeid2oaj4meiu3seRoiV7SOUBqkvfvl-JpCwbCo2j1ERJvx6pWmLKHSLJz_o1DqK_7dLWxtwPj10=):\nlesley@portnoylaw.com, to discuss their legal rights, or join the case via\nhttps://portnoylaw.com/adma-biologics-inc. The Portnoy Law Firm can provide a\ncomplimentary case evaluation and discuss investors’ options for pursuing\nclaims to recover their losses.\n\nAccording to the Complaint, ADMA Biologics and certain of its executives are\ncharged with failing to disclose material information in the Offering\nDocuments, violating federal securities laws.\n\nThe alleged false and misleading statements and omissions include, but are not\nlimited to, that: (i) the Company engaged in an undisclosed related party\ntransaction; (ii) the Company used channel stuffing to create an appearance of\nrevenue; (iii) the Company lacked adequate internal controls; (iv) as a\nresult, Defendants’ statements about the Company’s business, operations,\nand prospects were materially false and misleading and/or lacked a reasonable\nbasis at all relevant times. When the true details entered the market, the\nlawsuit claims that investors suffered damages.\n\nThe Portnoy Law Firm represents investors in pursuing claims caused by\ncorporate wrongdoing. The Firm’s founding partner has recovered over $5.5\nbillion for aggrieved investors. Attorney advertising. Prior results do not\nguarantee similar outcomes.\n\nLesley F. Portnoy, Esq.\nAdmitted CA, NY and TX Bar\nlesley@portnoylaw.com\n310-692-8883\nwww.portnoylaw.com\n\nAttorney Advertising\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/ea0dd9c0-6e41-4d5a-ad27-b277677af6df)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-07-21T14:45:30.132079931Z","server_sent_at_ms":1784645130132},"received_at":"2026-07-21T14:45:30.183Z","source_url":null},"analysis":{"id":"83240","press_release_id":"94197","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"legal_litigation","narrative":"Portnoy Law Firm announced a class action lawsuit against ADMA Biologics on behalf of investors who purchased securities between August 9, 2024 and March 25, 2026.\n\nThe complaint alleges that the company failed to disclose material information regarding undisclosed related party transactions and channel stuffing to create the appearance of revenue.\n\nInvestors have until August 10, 2026 to file a lead plaintiff motion; this release is a plaintiff law-firm solicitation, not a company disclosure.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress."},"keyFigures":null,"quotedText":"","namedEntities":{"people":[{"name":"Lesley F. Portnoy","role":"Attorney"}],"products":[],"companies":[{"name":"Portnoy Law Firm","relationship":"plaintiff law firm"},{"name":"ADMA Biologics, Inc.","ticker":"ADMA","relationship":"target"}],"dollarAmounts":[{"amount":"$5.5 billion","context":"historical recoveries by the firm's founding partner"}]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm shareholder solicitation issued by Portnoy Law Firm. No new disclosure from the issuer; no certified class, no settlement. Routine lead-plaintiff-deadline reminder."},"tickerRelevance":{"others":[],"primary":"ADMA"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Portnoy Law Firm announced a class action lawsuit against ADMA Biologics on behalf of investors who purchased securities between August 9, 2024 and March 25, 2026.\n\nThe complaint alleges that the company failed to disclose material information regarding undisclosed related party transactions and channel stuffing to create the appearance of revenue.\n\nInvestors have until August 10, 2026 to file a lead plaintiff motion; this release is a plaintiff law-firm solicitation, not a company disclosure.","key_figures":null,"named_entities":{"people":[{"name":"Lesley F. Portnoy","role":"Attorney"}],"products":[],"companies":[{"name":"Portnoy Law Firm","relationship":"plaintiff law firm"},{"name":"ADMA Biologics, Inc.","ticker":"ADMA","relationship":"target"}],"dollarAmounts":[{"amount":"$5.5 billion","context":"historical recoveries by the firm's founding partner"}]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-07-21T18:46:47.727Z","global_importance":15,"audience_relevance":10,"importance_components":{"tickerTier":"small-mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":null,"modelName":"glm-4.7"}}